Tag: livanova
Perceval sutureless valve data presented at EACTS 2020
LivaNova has announced new data from the Perceval Sutureless Implant Versus Standard-Aortic Valve Re...
COVID-19: LivaNova can modify indications of its cardiopulmonary products to help address virus
LivaNova has announced that several of its cardiopulmonary products are can now be used in the U...
Positive results for LivaNova’s Perceval sutureless valve
Three newly published studies highlight the safety, efficacy, and economic advantage of the Perv...
PRECLUDE study of Caisson TMVI system concludes
LivaNova has announced the conclusion of the PRELUDE feasibility study for its Caisson transcatheter...
LivaNova to buy TandemLife
LivaNova has entered into an agreement to acquire TandemLife, a privately held company focused on ad...
Optiflow arterial cannulae family launched onto the USA
LivaNova has received FDA 510(k) clearance for the US market launch of its Optiflow arterial can...
New literature review highlights that Perceval sutureless aortic valve is safe
Corey Adams (Health Science Center, St John’s, Canada) and others report in the latest issue of ...
LivaNova’s Perceval sutureless valve awarded Centers for Medicare and Medicaid add-on payment
LivaNova’s Perceval sutureless aortic heart valve has received approval from the US Centers for ...
LivaNova acquires Caisson Interventional
LivaNova has announced it has acquired the remaining outstanding interests in Caisson Interventional...
New data reaffirms value of Perceval for aortic valve replacement in aortic stenosis patients
LivaNova has announced the presentation of data from multiple studies demonstrating the safety a...
LivaNova to delist from London Stock Exchange
LivaNova has applied for the voluntary cancellation of its standard listing of ordinary shares with ...
